| Meridian Health Services Corp | |
|
1547 Ohio Ave Anderson IN 46016-1917 | |
| (765) 288-1928 | |
| Not Available |
| Full Name | Meridian Health Services Corp |
|---|---|
| Speciality | Clinic/Center |
| Location | 1547 Ohio Ave, Anderson, Indiana |
| Authorized Official Name and Position | Gary Gates (REVENUE CYCLE MANAGER) |
| Authorized Official Contact | 7652542685 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Meridian Health Services Corp 240 N Tillotson Ave Muncie IN 47304-3988 Ph: () - | Meridian Health Services Corp 1547 Ohio Ave Anderson IN 46016-1917 Ph: (765) 288-1928 |
| NPI Number | 1841756749 |
|---|---|
| Provider Enumeration Date | 02/15/2019 |
| Last Update Date | 06/14/2019 |
| Medicare PECOS PAC ID | 5597679845 |
|---|---|
| Medicare Enrollment ID | O20190405000497 |
News Archive
Physical performance capabilities, which decline across the lifespan, are strongly associated with daily levels of physical activity. The decrease in physical activity across the lifespan has consequences for health and well-being.
The age-old question of whether pride is the seventh sin or an adaptive virtue has been answered by two Northeastern University scientists.
Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.
MacuCLEAR, Inc. and Mystic Pharmaceuticals, Inc., announced today preliminary successful results of a Phase Ib Clinical Trial for the treatment and prevention of the progression of Age Related Macular Degeneration (AMD). The preliminary results indicated that MacuCLEAR's MC-1101 drug is safe and well tolerated by study participants, and has a biological effect on blood flow in the back of the retina.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841756749 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (* (Not Available)) | Primary |
News Archive
Physical performance capabilities, which decline across the lifespan, are strongly associated with daily levels of physical activity. The decrease in physical activity across the lifespan has consequences for health and well-being.
The age-old question of whether pride is the seventh sin or an adaptive virtue has been answered by two Northeastern University scientists.
Recent data suggest that epigenetic therapies are likely to provide additional clinical benefit to cancer patients when rationally combined with immunotherapeutic drugs, according to a review published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.
MacuCLEAR, Inc. and Mystic Pharmaceuticals, Inc., announced today preliminary successful results of a Phase Ib Clinical Trial for the treatment and prevention of the progression of Age Related Macular Degeneration (AMD). The preliminary results indicated that MacuCLEAR's MC-1101 drug is safe and well tolerated by study participants, and has a biological effect on blood flow in the back of the retina.
› Verified 7 days ago
Anderson Family Health Specialists Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 Medical Arts Blvd, Suite 100, Anderson, IN 46011 Phone: 765-298-5700 Fax: 765-298-4913 | |
Five J Woodall Medical Director Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 299 E 360 N, Anderson, IN 46012 Phone: 765-642-8446 Fax: 765-642-7934 | |
Bridges Campbell & Woodall Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1302 S Madison Ave, Anderson, IN 46016 Phone: 765-644-3673 Fax: 765-644-3680 | |
Craig Groninger Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-1851 Fax: 765-642-3756 | |
United Family Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 417 W 38th St, Anderson, IN 46013 Phone: 765-400-0380 Fax: 765-400-0381 | |
Caesars Health Center Hoosier Park Anderson Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4500 Dan Patch Cir, Anderson, IN 46013 Phone: 765-609-4711 Fax: 765-609-4713 | |
Indiana Standardbred Association Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3029 E 41st St, Anderson, IN 46013 Phone: 317-621-1230 |